Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Nantahala Capital Management, LLC
Form 13F · Q2 2026

Nantahala Capital Management, LLC

CIK 1472322Filed 2026-08-1913F-HR/A View the filing on EDGAR ↗
$3.0B
Reported book value
155
Positions
12
Quarters on record
Top 50
Positions

Nantahala Capital Management, LLC — holdings

Top 50 positions of 155, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TBBK Bancorp Inc Del1.2M−10.2%$78M2.6%
2BVS Bioventus Inc6.0M−2.0%$57M1.9%
3HGV Hilton Grand Vacations Inc1.0M−31.7%$54M1.8%
4SVRA Savara Inc7.0M−5.0%$43M1.4%
5ETON Eton Pharmaceuticals Inc1.2M+0.0%$43M1.4%
6AMRX Amneal Pharmaceuticals Inc2.3M−20.2%$39M1.3%
7EOLS Evolus Inc5.6M−12.2%$39M1.3%
8AVTX Avalo Therapeutics Inc1.9M+50.8%$34M1.1%
9LBRX Lb Pharmaceuticals Inc1.1M+0.0%$34M1.1%
10AVR Anteris Technologies Global3.4M−38.8%$33M1.1%
11ABEO Abeona Therapeutics Inc5.1M+2.5%$32M1.1%
12PTON Peloton Interactive Inc5.1M−57.4%$30M1.0%
13ESTA Establishment Labs Hldgs Inc335,830−59.7%$29M1.0%
14XTANT MED HLDGS INC Xtant Med Hldgs Inc68.4M+0.0%$29M1.0%
15JACK Jack In The Box Inc1.7M+12.1%$27M0.9%
16GOGO Gogo Inc8.7M−2.1%$27M0.9%
17IMAX Imax Corp658,009+27.6%$26M0.9%
18ZVRA Zevra Therapeutics Inc1.8M−28.7%$26M0.9%
19TITAN MACHY INC Titan Machy Inc1.1M−9.7%$24M0.8%
20RMR Rmr Group Inc1.1M+0.0%$24M0.8%
21FOSL Fossil Group Inc5.5M+1.9%$23M0.8%
22FOX FACTORY HLDG CORP Fox Factory Hldg Corp1.3M−11.9%$22M0.7%
23MLYS Mineralys Therapeutics Inc820,481−8.4%$22M0.7%
24RDNW Ridenow Group Inc3.3M+0.0%$22M0.7%
25UNIQURE NV Uniqure Nv455,660+92.2%$21M0.7%
26AURA Aura Biosciences Inc3.0M+39.4%$21M0.7%
27AGMB Agomab Therapeutics Nv1.6M+30.7%$20M0.7%
28FULC Fulcrum Therapeutics Inc5.5M+79.5%$20M0.7%
29BNTC Benitec Biopharma Inc1.5M+3.5%$20M0.7%
30ADMA Adma Biologics Inc2.4M—$20M0.7%
31CWH Camping World Hldgs Inc2.6M−21.7%$19M0.6%
32BCRX Biocryst Pharmaceuticals Inc1.9M−4.3%$19M0.6%
33MDXG Mimedx Group Inc4.8M+40.3%$18M0.6%
34ABIVAX SA Abivax Sa133,759−2.5%$18M0.6%
35USNA Usana Health Sciences Inc810,074+0.0%$17M0.6%
36GLUE Monte Rosa Therapeutics Inc651,993+0.0%$16M0.5%
37TNGX Tango Therapeutics Inc500,659−60.0%$16M0.5%
38GERN Geron Corp12.2M+8.9%$16M0.5%
39VOR Vor Biopharma Inc845,000—$16M0.5%
40KROS Keros Therapeutics Inc1.4M+3.7%$15M0.5%
41SLN Silence Therapeutics Plc1.3M−37.3%$15M0.5%
42APYX Apyx Medical Corporation3.3M−4.9%$15M0.5%
43JCAP Jefferson Capital Inc750,000+0.0%$15M0.5%
44HLF Herbalife Ltd1.1M−18.1%$15M0.5%
45PLNT Planet Fitness Master Issuer279,000—$15M0.5%
46VSTM Verastem Inc3.6M+0.0%$14M0.5%
47DSGR Distribution Solutions Grp I494,581+0.0%$14M0.4%
48RYN Rayonier Advanced Matls Inc1.7M+6.1%$13M0.4%
49HLXC Helix Acquisition Corp Iii1.2M+0.0%$13M0.4%
50ADCT Adc Therapeutics Sa12.3M+120.2%$13M0.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.